Gabriela Torrea

<i>Yersinia pestis</i> , the cause of plague, is a recently emerged clone of <i>Yersinia pseudotuberculosis</i>

Mark Achtman, Kerstin Zurth, Giovanna Morelli et al. · Proceedings of the National Academy of Sciences · 1999 · 1.1K citations

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

Andrew Nunn, Patrick Phillips, Sarah Meredith et al. · New England Journal of Medicine · 2019 · 389 citations · Full text

Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard

Armand Van Deun, K. J. M. Aung, Valentin Bola et al. · Journal of Clinical Microbiology · 2013 · 240 citations · Full text

Tuberculosis Prevention, Insufficient Specificity, Pathology +22

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 134 citations · Full text

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis, Tuberculosis Prevention +7

Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial

Andrew Nunn, I. D. Rusen, Armand Van Deun et al. · Trials · 2014 · 129 citations · Full text